Generated: December 13, 2017
DrugPatentWatch Database Preview
Patent Applications for NYMALIZE
« Back to Dashboard
US Patent Applications for NYMALIZE
|US Patent Application
||Patent Filing Date
||Patent Application Status
|► Subscribe||► Subscribe||Oral delivery of discrete units||2001-01-19||Patented Case||2001-12-06|
|► Subscribe||► Subscribe||FATTY ACID-PHARMACEUTICAL AGENT CONJUGATES||2000-12-05||Patented Case||2003-05-21|
|► Subscribe||► Subscribe||CONTRAST AGENTS||1999-04-14||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2014-05-19|
|► Subscribe||► Subscribe||Pharmaceutical composition for angiotensin II-mediated diseases||2001-01-12||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2014-03-17|
|► Subscribe||► Subscribe||SOLID SOLUTION BEADLET||1998-09-18||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2016-03-14|
|► Subscribe||► Subscribe||GENE TRANSCRIPTION AND IONIZING RADIATION: METHODS AND COMPOSITIONS||2000-12-05||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2014-06-09|
|► Subscribe||► Subscribe||DIAGNOSING AN ANIMAL FOR PYROPHOSPHATE GOUT, OSTEOPOROSIS , OR OSTEOARTHRITIS BY ASSAYING INTRACELLULAR PYROPHOSPHATE CONTENT IN PERIPHERAL BLOOD CELLS||2001-01-04||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2011-03-21|
|► Subscribe||► Subscribe||PHARMACEUTICAL COMPOSITION FOR ANGIOTENSIN II-MEDIATED DISEASES||2001-02-15||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2014-08-11|
|► Subscribe||► Subscribe||Compositions and methods for the treatment of anorectal disorders||2001-01-23||Abandoned -- Failure to Respond to an Office Action||2006-02-21|
|► Subscribe||► Subscribe||Tryptophanyl-esters and their n-acyl derivatives for preventing and treating diseases caused or aggravated by oxidation processes||2001-03-16||Abandoned -- Failure to Respond to an Office Action||2004-03-19|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.